These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2964264)

  • 21. [Value of hormone therapy in metastasizing breast cancer].
    Samonigg H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological responses of tamoxifen in the fetal and newborn vagina and uterus of the guinea-pig and in the R-27 mammary cancer cell line.
    Pasqualini JR; Giambiagi N; Sumida C; Nguyen BL; Gelly C; Mayrand C; Lecerf F
    J Steroid Biochem; 1986 Jan; 24(1):99-108. PubMed ID: 3702432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of tamoxifen related to estrogen receptor level.
    Rose C; Thorpe SM; Løber J; Daenfeldt JL; Palshof T; Mouridsen HT
    Recent Results Cancer Res; 1980; 71():134-41. PubMed ID: 6988911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endocrine therapy of breast cancer].
    Jonat W; Maass H
    Zentralbl Gynakol; 1987; 109(10):617-27. PubMed ID: 2956805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trial.
    Tormey DC; Gray R; Abeloff MD; Roseman DL; Gilchrist KW; Barylak EJ; Stott P; Falkson G
    J Clin Oncol; 1992 Dec; 10(12):1848-56. PubMed ID: 1453199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant hormone treatment and chemotherapy in postmenopausal women with operable breast cancer: a retrospective analysis.
    Oriana S; Coradini D; Sasso GM; Di Fronzo G
    Anticancer Res; 1991; 11(6):2199-205. PubMed ID: 1776861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
    Iino Y; Ishikawa H; Izuo M; Takikawa H
    Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer.
    van Veelen H; Willemse PH; Tjabbes T; Schweitzer MJ; Sleijfer DT
    Cancer; 1986 Jul; 58(1):7-13. PubMed ID: 2939943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.
    Waseda N; Kato Y; Imura H; Kurata M
    Cancer Res; 1981 May; 41(5):1984-8. PubMed ID: 7214366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiestrogen binding sites in human breast cancer biopsies. Measurement ligand-specificity and affinity, and correlation to estrogen and progesterone receptors.
    Fernö M; Borg A
    Anticancer Res; 1985; 5(3):307-12. PubMed ID: 4015045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
    Nomura Y; Tashiro H; Hisamatsu K; Toi M
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of sequential treatment with ethynyloestradiol and medroxyprogesterone acetate on oestrogen and progestogen receptors in breast cancer.
    Ghilchik M; Shaikh NA; Beranek PA; Reed MJ; Braunsberg H
    J Steroid Biochem; 1989; 34(1-6):403-5. PubMed ID: 2533948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment.
    Howell A; Harland RN; Barnes DM; Baildam AD; Wilkinson MJ; Hayward E; Swindell R; Sellwood RA
    Cancer Res; 1987 Jan; 47(1):300-4. PubMed ID: 3791215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.
    Fisher B; Redmond C; Brown A; Wickerham DL; Wolmark N; Allegra J; Escher G; Lippman M; Savlov E; Wittliff J
    J Clin Oncol; 1983 Apr; 1(4):227-41. PubMed ID: 6366135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate.
    Grenman SE; Roberts JA; England BG; Grönroos M; Carey TE
    Gynecol Oncol; 1988 Jun; 30(2):239-50. PubMed ID: 2967231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone steroid receptor variation after tamoxifen administration in endometrial adenocarcinoma from postmenopausal patients.
    Di Fronzo G; Ronchi E; Cappelletti V; Luciani L; Coradini D; Oriana S; Miodini P; Andreola S
    Cancer Detect Prev; 1986; 9(3-4):323-30. PubMed ID: 3742507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
    Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
    Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
    Jordan VC; Fritz NF; Tormey DC
    Cancer Res; 1987 Jan; 47(2):624-30. PubMed ID: 3098415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hormonotherapy of metastatic breast cancer with tamoxifen and medroxyprogesterone acetate. Randomized trial comparing alternating sequences with successive applications].
    Mauriac L; Durand M; Bonichon F; Chauvergne J
    Bull Cancer; 1986; 73(2):148-54. PubMed ID: 2942203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.